thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » New COVID-19 Study: Hydroxychloroquine Causing Fatal Cardiovascular Complications

COVID-19

New COVID-19 Study: Hydroxychloroquine Causing Fatal Cardiovascular Complications

TheNewsFacts
Last updated: September 1, 2021 12:40 pm
TheNewsFacts
Share
New COVID-19 Study: Hydroxychloroquine Causing Fatal Cardiovascular Complications
SHARE

In a new covid-19 study research study on drug treatment including Hydroxychloroquine published in The American Journal of Medicine, researchers from Florida Atlantic has warned the negative outcome of prescribing hydroxychloroquine for the treatment of COVID-19.

In 2021, in the US alone, there have been more than 560,000 prescriptions of hydroxychloroquine for the prevention, post-exposure, and treatment of Covid-19. In 2020, the 890,000 prescriptions for hydroxychloroquine were nine-fold greater than the previous years.

The American Journal of Medicine, researchers from Florida Atlantic University, reviewed the recent major randomised, double-blind placebo-controlled trials and present an updated meta-analysis of hydroxychloroquine in post-exposure prophylaxis as well as in hospitalised patients.

In addition to a lack of significant benefit, the new evidence shows some suggestion of harm.

The prior reassuring safety profile of hydroxychloroquine is applicable to patients with lupus and rheumatoid arthritis, both of which are of greater prevalence in younger and middle-age women, whose risks of fatal heart outcomes due to hydroxychloroquine are reassuringly very low.

In contrast, the risks of hydroxychloroquine for patients with Covid-19 are significantly higher because fatal cardiovascular complications due to these drugs are so much higher in older patients and those with existing heart disease or its risk factors, both of whom are more predominant in men, researchers said.

Last year, the same researchers issued a plea for a moratorium on prescription of hydroxychloroquine in prevention or treatment pending the outcome of ongoing randomised trials.

“The updated randomised evidence provides even stronger support for the halt on prescribing hydroxychloroquine in the prevention or treatment of Covid-19,” said Charles H. Hennekens, Professor in FAU’s Schmidt College of Medicine.

“Premature and avoidable deaths will continue to occur if people take hydroxychloroquine and avoid the public health strategies of proven benefit, which include vaccinations and masking,” he added.

A WHO-led trial, last year, evaluated four drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon — for treatment against Covid. The results showed that the drugs had little or no effect on hospitalised patients with Covid-19. Remdesivir and HCQ did not affect the degree of respiratory failure or inflammation.

Share This Article
Twitter Email Copy Link Print
Previous Article Money Laundering: Director Puri Jagannadh in a Tight Spot as ED Grills Him Money Laundering: Director Puri Jagannadh in a Tight Spot as ED Grills Him
Next Article Virtual Private Network Likely to be Banned In India Virtual Private Network Likely to be Banned In India

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

COVID-19 Vaccines vs Natural Shield What You Need is…

The science of COVID-19 vaccines versus Natural Shield is a big debate. What should one…

By TheNewsFacts

Pfizer’s Omicron targeted Vaccine Trial Begins

As Omicron is disturbing life across globe Pfizer and BioNTech made it public on Tuesday…

By TheNewsFacts

WWE Royal Rumble 2024: Cody Rhodes Wins, The Other Surprises

WWE's first premium live event of the year, the Royal Rumble 2024, took place on…

By TheNewsFacts

You Might Also Like

Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By NewsFacts Bureau
Covid-19 JN.!
COVID-19Health

JN.1, A New Subvariant of COVID-19 in Kerala: Health Ministry Vigilant

By SK Panicker
India's Covid-19 Cases Continue to Decline with 9,355 New Infections
COVID-19

India’s Covid-19 Cases Continue to Decline with 9,355 New Infections

By TheNewsFacts
COVAXIN
COVID Vaccines

COVAXIN production to be demand-driven, says Bharat Biotech

By TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?